An interventional study of Rice with tea extract and Rice without tea extract in Healthy, sponsored by Unilever R&D. Completed at 1 site in Ireland. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-07-28.
Sponsored by Unilever R&D · Not applicable, Interventional, and Other
This study is designed as a randomized, single blind (data evaluation), placebo controlled, full cross-over study and conducted in 166 (including 10% drop out) males and females, aged ≥ 18 and ≤ 65 and waist circumference of >80 cm for women and >94 cm for men (indicating increased risk of metabolic complications (WHO)) and having a sedentary lifestyle. Subjects will receive rice with a tea extract and rice without a tea extract.
There will be three visits to the test facility: one screening visit and two intervention visits. During the intervention visits venous blood samples will be collected for the analysis of plasma glucose (t = -30m, -5m, 15m, 30m, 45m, 1h, 1h 30m, 2h and 3h, relative to the start of rice consumption ) and serum insulin (t = -5m, 30m, 1h, 2h and 3h).
Between the two intervention visits subjects have an interval of one week. This interval is required to minimize subject discomfort from repeated blood sampling.
Unilever R&D is the lead sponsor of 69 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Rice with tea extract
Other: Rice with tea extract
Rice without tea extract
Other: Rice without tea extract
Rice with tea extract
Rice without tea extract
Incremental area under the plasma glucose versus time curve
Time frame: 0-2 hours
Incremental area under the plasma glucose versus time curve
Time frame: 0-3 hours
Maximum venous glucose concentration
Time frame: 0-3 hours
Total area under the post prandial insulin versus time curves
Time frame: 0-2 hours
Total area under the post prandial insulin versus time curves
Time frame: 0-3 hours
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Unilever R&D